digital therapeutics

By Dave Muoio 03:02 pm July 22, 2020
Editor's note: This story has been updated with the timing and size of the pilot. Scottsdale, Arizona-based Magellan Health announced today that it has launched a pilot of Boston Children's Hospital spin-out Neuromotion Labs' Mightier, a biofeedback video game platform designed to help children regulate their emotions. Since June 22, the managed care company has begun supplying members with...

(Photo by Jeff Schear/Getty Images for Kennedy Forum)

By Laura Lovett 02:46 pm July 1, 2020
Over the last decade, the addiction and mental health space has becoming increasingly digital – so much so that the first prescription digital therapeutic, Pear’s ReSET, scored FDA clearance nearly three years ago. While more and more players begin to join the so-called "DTx" space, the technology is yet to hit the mainstream radar, but a new coalition is looking to change that.  A list of high-...
By HIMSS Media 02:54 pm June 26, 2020
In the newest episode of HIMSSCast, MobiHealthNews founding editor Brian Dolan, now founder and lead writer at Exits and Outcomes, joins the host, Jonah Comstock, Managing Editor Laura Lovett and Associate Editor Dave Muoio for a bit of a post-mortem on Proteus Digital Health, the sensor-enabled pill company that filed for Chapter 11 bankruptcy protection last week.     More related to this...
By Anthony Pannozzo 04:20 pm June 25, 2020
About the author: Anthony Pannozzo is chief design officer (for North American and Asia) and global healthcare lead at frog, a design consultancy and a company of the Altran Group. Healthcare has often been accused (fairly and unfairly) of being too slow to change or adapt to new technologies and the ideas they inspire. While change is hard for everyone, in a space like healthcare change meets...

Credit: Kaia Health

By Sara Mageit 05:00 am June 18, 2020
Digital therapeutics company for chronic conditions, Kaia Health, today announced that it closed a $26 million Series B funding round, bringing its total funds raised to date to $50 million.  The round was led by Optum Ventures, Idinvest and capital300 with participation from existing investors Balderton Capital and Heartcore Capital, as well as Symphony Ventures, an investment partnership with...
By Dave Muoio 02:51 pm June 16, 2020
Proteus Digital Health, maker of an ingestible sensor for tracking medication adherence, filed for Chapter 11 bankruptcy protection yesterday. The news comes months after word that the company had furloughed much of its staff, reassessed its high-profile partnership with Otsuka Pharmaceutical and shifted away from its primary focus area of mental disorder treatment. The "smart pill" maker...
By Dave Muoio 05:39 pm June 15, 2020
After years of waiting, Akili Interactive has finally received FDA De Novo marketing authorization for EndeavorRx, its video-game digital therapeutic for children aged 8 to 12 years with ADHD. This is the first game-based therapeutic that the FDA has greenlit for any condition, the regulatory agency noted in its announcement. It is also the first authorization for Akili, which has a handful of...
By Dave Muoio 02:51 pm June 3, 2020
WellDoc's BlueStar chronic disease-management tool has picked up another 510(k) FDA clearance that will allow it to support adult Type 2 diabetes patients using long-acting basal insulin. The feature was announced by WellDoc this morning, but cleared by the agency in April, according to a listing on its website. The new capability takes the form of a new program within the prescription BlueStar...
By Aline Noizet 02:16 am April 29, 2020
Dr. Morcillo is the director of internal medicine Hospital Cima Sanitas in Barcelona and the medical director of Sanitas digital hospital. He is an active advocate and user of digital technologies in his daily practice. He will join the HIMSS & Health 2.0 European Digital Event (7-11 September 2020) as an expert in the session on digital therapeutics. The below Q&A has been edited for...
By Dave Muoio 06:00 am April 22, 2020
Less than a week after FDA opened the faucet for digital health products treating psychiatric conditions during the COVID-19 health crisis, Akili has fast-tracked and released its approval-pending digital therapeutic for children with ADHD. Now known as Endeavor and flanked by a symptom tracker and caretaker support line, the video game-like app will be provided at no cost for a limited time to...